Results 201 to 210 of about 281,573 (395)
Engineering antibodies with cancer‐associated binding sites
This review describes antibodies that perform direct/indirect roles in cancer treatment by binding to effective targets and discusses how antibodies kill tumors and modulate tumor microenvironment through these targets. The classification of expression systems for antibody production is summarized to guide appropriate selection based on different ...
Yinqi Tian+4 more
wiley +1 more source
A Human Alloantiserum Precipitates Ia-Like Molecules from Chronic Lymphocytic Leukemia Cells [PDF]
Sten Nilsson+5 more
openalex +1 more source
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia.
J. Burger+33 more
semanticscholar +1 more source
This review highlights the complex roles of cellular senescence in cancer progression and suppression, discusses the mechanisms and regulatory pathways involved, and evaluates the efficacy of the “One‐Two punch” sequential treatment approach while addressing emerging challenges in this novel therapeutic strategy.
Qiuming Pan+12 more
wiley +1 more source
Monoclonal immunoglobulin rescue from a patient with chronic lymphocytic leukemia and autoimmune hemolytic anemia [PDF]
Karol Sikora, J Krikorian, Ronald Levy
openalex +1 more source
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.
G. Calin+22 more
semanticscholar +1 more source
ABSTRACT The subfamily Gomphrenoideae is composed of about 480 accepted species, many of which have been historically used as medicinal plants, reason why they have been studied in terms of chemical profile, biological activity, and safety. This review consolidates the advances in research on this subfamily over the past 47 years, emphasizing its ...
Dayanna Isabel Araque Gelves+3 more
wiley +1 more source
STUDIES ON LYMPHOCYTES OF CHRONIC LYMPHOCYTIC LEUKEMIA
Shõzo TOYOMASU
openalex +2 more sources
Further characterization of the circulating cell in chronic lymphocytic leukemia [PDF]
EF Schultz, S Davis, AD Rubin
openalex +1 more source